Sign up
Pharma Capital

M Pharma's Gary Thompson 'excited' to receive US Extrinsa trademark

Gary Thompson, president and chief executive of M Pharmaceutical Inc (CSNX:MQ, OTCMKTS:MPHMF) tells Proactive they've received an official trademark for Extrinsa from the US patent office.

The treatment is a solution for female sexual dysfunction (FSD).

 

View full MQ profile

Callitas Therapeutics Inc Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.